Role of natural and synthetic compounds in modulating NRF2/KEAP1 signaling pathway in prostate cancer

G Tossetta, S Fantone, D Marzioni, R Mazzucchelli - Cancers, 2023 - mdpi.com
Simple Summary Several studies showed that oxidative stress is involved in cancer
occurrence, development, progression chemoresistance and radio resistance. The nuclear …

An updated patent review of Nrf2 activators (2020-present)

Z Zhao, R Dong, K Cui, Q You… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction The nuclear factor erythroid 2-related factor 2 (Nrf2) is a pivotal transcription
factor that controls the expression of numerous cytoprotective genes and regulates cellular …

Metabolic changes during prostate cancer development and progression

AMK Beier, M Puhr, MB Stope, C Thomas… - Journal of cancer …, 2023 - Springer
Metabolic reprogramming has been recognised as a hallmark in solid tumours. Malignant
modification of the tumour's bioenergetics provides energy for tumour growth and …

Knockout of NRF2 triggers prostate cancer cells death through ROS modulation and sensitizes to cisplatin

MCS Mancini, AP Morelli, MB Severino… - Journal of Cellular …, 2022 - Wiley Online Library
Prostate cancer (PCa) represents the second most common cancer in men and affects
millions worldwide. Chemotherapy is a common treatment for PCa but the development of …

Attenuation of pancreatic cancer in vitro and in vivo via modulation of Nrf2 and NF-κB signaling pathways by natural compounds

M Cykowiak, R Kleszcz, M Kucińska, J Paluszczak… - Cells, 2021 - mdpi.com
Pancreatic cancer is a disease in which deregulation of signaling pathways plays a key role,
thus searching for their novel modulators is a promising therapeutic strategy. Hence, in this …

The ERα-NRF2 signalling axis promotes bicalutamide resistance in prostate cancer

L Tian, Y Peng, K Yang, J Cao, X Du, Z Liang… - Cell Communication and …, 2022 - Springer
Background Bicalutamide is a nonsteroidal antiandrogen widely used as a first-line clinical
treatment for advanced prostate cancer (PCa). Although patients initially show effective …

Alpha-Lipoic Acid Reduces Cell Growth, Inhibits Autophagy, and Counteracts Prostate Cancer Cell Migration and Invasion: Evidence from In Vitro Studies

S Bossio, A Perri, R Gallo, A De Bartolo… - International journal of …, 2023 - mdpi.com
Alpha-lipoic acid (ALA) is a natural antioxidant dithiol compound, exerting antiproliferative
and antimetastatic effects in various cancer cell lines. In our study, we demonstrated that …

Pharmacological significance of Heme Oxygenase 1 in prostate cancer

M Ben-Eltriki, EJ Gayle, N Walker, S Deb - Current Issues in Molecular …, 2023 - mdpi.com
Heme oxygenase 1 (HO-1) is a detoxifying antioxidant microsomal enzyme that regulates
inflammation, apoptosis, cell proliferation, and angiogenesis in prostate cancer (PCa). This …

[HTML][HTML] Elucidation of scandenolone as anti-cancer activity through impairment of the metabolic and signaling vulnerabilities in prostate cancer

P Basavaraj, PF Hsieh, WP Jiang, DT Bau… - Biomedicine & …, 2023 - Elsevier
Prostate cancer (PCa) is the most prevalent men's cancer in America and Western countries.
No effective therapies are currently available for PCa aggressiveness, including castration …

[HTML][HTML] Heme Oxygenase-1 and Prostate Cancer: Function, Regulation, and Implication in Cancer Therapy

RJ Salloom, IM Ahmad, DZ Sahtout, MJ Baine… - International Journal of …, 2024 - mdpi.com
Prostate cancer (PC) is a significant cause of mortality in men worldwide, hence the need for
a comprehensive understanding of the molecular mechanisms underlying its progression …